Literature DB >> 26941990

Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion.

Rahul Rajeev1, Brittany Klooster1, Kiran K Turaga1.   

Abstract

Complex surgical operations performed at centers of high volume have improved outcomes due to improved surgical proficiency, and betters systems of care including avoidance of errors. Cytoreductive surgery (CRS) and hyperthermic intra-peritoneal chemoperfusion (HIPEC), which has been shown to be an oncologically effective strategy for peritoneal carcinomatosis (PC), is one such procedure with significant morbidity and mortality. The learning curve to reach technical proficiency in CRS + HIPEC is about 140-220 cases for a center. Focus on improving surgical proficiency through training, improving systems of care through partnerships and reporting mechanisms for quality could reduce the time to proficiency.

Entities:  

Keywords:  Learning curve; cytoreductive surgical procedures; high-volume hospitals; induced hyperthermia; peritoneal neoplasms

Year:  2016        PMID： 26941990      PMCID： PMC4754306          DOI： 10.3978/j.issn.2078-6891.2015.099

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


  39 in total

1.  Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program.

Authors:  S F Khuri; J Daley; W Henderson; K Hur; M Hossain; D Soybel; K W Kizer; J B Aust; R H Bell; V Chong; J Demakis; P J Fabri; J O Gibbs; F Grover; K Hammermeister; G McDonald; E Passaro; L Phillips; F Scamman; J Spencer; J F Stremple
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

2.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

3.  Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures.

Authors:  O Glehen; D Osinsky; E Cotte; F Kwiatkowski; G Freyer; S Isaac; V Trillet-Lenoir; A C Sayag-Beaujard; Y François; J Vignal; F N Gilly
Journal:  Ann Surg Oncol       Date:  2003-10       Impact factor: 5.344

Review 4.  A systematic review of the impact of volume of surgery and specialization on patient outcome.

Authors:  M M Chowdhury; H Dagash; A Pierro
Journal:  Br J Surg       Date:  2007-02       Impact factor: 6.939

5.  Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres.

Authors:  Shigeki Kusamura; Dario Baratti; Salvatore Virzì; Serena Bonomi; Domenico Rosario Iusco; Antonio Grassi; Ionut Hutanu; Marcello Deraco
Journal:  J Surg Oncol       Date:  2012-08-23       Impact factor: 3.454

6.  Safety and quality outcomes in peritoneal surface malignancy patients: developing a national center for excellence in Colombia.

Authors:  Fernando Arias; Gabriel Herrera-Almario; Marcos E Pozo; Eduardo Londoño-Schimmer; Jorge M Otero; Andres Cardona; Natalia Cortes; Marta Mora
Journal:  Ann Surg Oncol       Date:  2014-09-20       Impact factor: 5.344

7.  Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008.

Authors:  S Jane Henley; Theodore C Larson; Manxia Wu; Vinicius C S Antao; Mary Lewis; Germania A Pinheiro; Christie Eheman
Journal:  Int J Occup Environ Health       Date:  2013 Jan-Mar

8.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: initial experience in Oaxaca, Mexico.

Authors:  Rolando García-Matus; Carlos Alberto Hernández-Hernández; Omar Leyva-García; Sergio Vásquez-Ciriaco; Guillermo Flores-Ayala; Quetzalli Navarro-Hernández; Gerardo Pérez-Bustamante; Norma Miriam Valencia-Mijares; Jesus Esquivel
Journal:  Am Surg       Date:  2012-09       Impact factor: 0.688

9.  Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.

Authors:  Edward A Levine; John H Stewart; Perry Shen; Gregory B Russell; Brian L Loggie; Konstantinos I Votanopoulos
Journal:  J Am Coll Surg       Date:  2013-12-21       Impact factor: 6.113

10.  Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan.

Authors:  Akiyoshi Mizumoto; Emel Canbay; Masamitsu Hirano; Nobuyuki Takao; Takayuki Matsuda; Masumi Ichinose; Yutaka Yonemura
Journal:  Gastroenterol Res Pract       Date:  2012-06-18       Impact factor: 2.260
View more
  11 in total

1.  Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative.

Authors:  Nick C Levinsky; Mackenzie C Morris; Koffi Wima; Jeffrey J Sussman; Syed A Ahmad; Jordan M Cloyd; Charles Kimbrough; Keith Fournier; Andrew Lee; Sean Dineen; Sophie Dessureault; Jula Veerapong; Joel M Baumgartner; Callisia Clarke; Mohammad Y Zaidi; Charles A Staley; Shishir K Maithel; Jennifer Leiting; Travis Grotz; Laura Lambert; Ryan J Hendrix; Sean Ronnekleiv-Kelly; Courtney Pokrzywa; Mustafa Raoof; Oliver S Eng; Fabian M Johnston; Jonathan Greer; Sameer H Patel
Journal:  J Gastrointest Surg       Date:  2019-08-19       Impact factor: 3.452

2.  Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?

Authors:  Christopher W Mangieri; Cristian D Valenzuela; Ian B Solsky; Richard A Erali; Konstantinos I Votanopoulos; Perry Shen; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2022-08-15       Impact factor: 4.339

3.  The Road to Technical Proficiency in Cytoreductive Surgery for Peritoneal Carcinomatosis: Risk-Adjusted Cumulative Summation Analysis.

Authors:  Francesco Santullo; Carlo Abatini; Miriam Attalla El Halabieh; Federica Ferracci; Claudio Lodoli; Lorenzo Barberis; Francesco Giovinazzo; Andrea Di Giorgio; Fabio Pacelli
Journal:  Front Surg       Date:  2022-05-18

4.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis.

Authors:  Lynne M Ellison; Yangao Man; Alexander Stojadinovic; Hongwu Xin; Itzhak Avital
Journal:  Chin J Cancer Res       Date:  2017-02       Impact factor: 5.087

5.  Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria.

Authors:  Kogler Pamela; Zitt Matthias; Kafka-Ritsch Reinhold; Punter Julia; Müssigang Peter; Perathoner Alexander; Öfner Dietmar
Journal:  J Gastrointest Surg       Date:  2018-01-23       Impact factor: 3.452

6.  Trends in peritoneal surface malignancies: evidence from a Czech nationwide population-based study.

Authors:  Dušan Klos; Juraj Riško; Martin Loveček; Pavel Skalický; Ivana Svobodová; Denisa Krejčí; Bohuslav Melichar; Beatrice Mohelníková-Duchoňová; Radmila Lemstrová
Journal:  World J Surg Oncol       Date:  2019-11-06       Impact factor: 2.754

7.  ASO Author Reflections: Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method.

Authors:  Kjersti Flatmark; Faheez Mohamed
Journal:  Ann Surg Oncol       Date:  2020-06-03       Impact factor: 5.344

8.  Practice patterns, attitudes, and knowledge among clinicians regarding hyperthermic intraperitoneal chemotherapy and pressurized intraperitoneal aerosol chemotherapy: a national survey by Indian society of peritoneal surface malignancies (ISPSM).

Authors:  Sampige Prasanna Somashekhar; Kumar C Rohit; S V S Deo; Kyatsandra Rajagopal Ashwin
Journal:  Pleura Peritoneum       Date:  2020-08-31

9.  Perceptions in the management of colorectal peritoneal metastases: A bi-national survey of colorectal surgeons.

Authors:  Vignesh Narasimhan; Satish Warrier; Michael Michael; Jacob McCormick; Robert Ramsay; Craig Lynch; Alexander Heriot
Journal:  Pleura Peritoneum       Date:  2019-10-30

10.  Is the blood of a surgeon performing HIPEC contaminated by irinotecan, its major metabolites and platinum compounds?

Authors:  Guillaume Saint-Lorant; Simon Rodier; Jean-Marc Guilloit; Sophie Ndaw; Mathieu Melczer; Stéphanie Lagadu; Agnès Palix; Raphaël Delépée
Journal:  Pleura Peritoneum       Date:  2021-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.